Stephanie Mita, DPM
Podiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 6
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
6 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mita’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
6 of 6 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$25,343
Medicare paid this office $25,343 for 161 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 62 | $4,130 | $51 |
| Removal of bone, 20.0 sq cm or less | 12 | $2,409 | $185 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $2,352 | $73 |
| Removal of skin and tissue, 20.0 sq cm or less | 24 | $2,069 | $53 |
| Return visit (30+ min) | 19 | $1,731 | $82 |
See all 9 services
| Short return visit (20+ min) | 62 | $4,130 | $51 |
| Removal of bone, 20.0 sq cm or less | 12 | $2,409 | $185 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $2,352 | $73 |
| Removal of skin and tissue, 20.0 sq cm or less | 24 | $2,069 | $53 |
| Return visit (30+ min) | 19 | $1,731 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 65 | $1,646 | $18 |
| New patient visit (30+ min) | 15 | $907 | $60 |
| Removal of noncancer thickened skin growth, 2-4 growths | 21 | $562 | $17 |
| Removal of noncancer thickened skin growth, 1 growth | 18 | $317 | $12 |
Procedures Medicare counted
| Removal of nail tissue | 150 | More than 72% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 84 | More than 84% of doctors who do this |
| Removal or shaving of skin growth | 74 | More than 82% of doctors who do this |
Who their Medicare patients are
161 Original Medicare patients in 2024. Average age 71 · Under 65 24% · 85 and older 17% · Women 40% · Also on Medicaid 88% · Health risk score 2.91. Sicker patients than 9 in 10 peers; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 73% · Chronic kidney disease 45% · Heart failure 35% · Coronary heart disease 30% · Depression 28% · Atrial fibrillation 24% · Cancer 13% · Dementia 12% · Stroke 12% · COPD 9%.
The office billed $325,592, Medicare allowed $34,076 and paid $25,343; for 436 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 161 | 436 | 71 | 2.91 | $325,592 | $25,343 |
| 2023 | 118 | 282 | 70 | 3.27 | $224,484 | $16,181 |
| 2022 | 130 | 341 | 69 | 2.71 | $257,655 | $19,327 |
| 2021 | 124 | 336 | 70 | 2.84 | $180,820 | $17,109 |
| 2020 | 91 | 312 | 68 | 3.06 | $192,950 | $17,683 |
| 2019 | 59 | 134 | 69 | 2.25 | $87,164 | $7,785 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 33 | $2,196 | $56 |
| Removal of fingernails or toenails, 6 or more nails | 59 | $1,502 | $20 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,455 | $73 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $1,261 | $55 |
| Short return visit | 13 | $490 | $31 |
| Removal of noncancer thickened skin growth, 2-4 growths | 15 | $385 | $17 |
2022: 7 services
| Short return visit (20+ min) | 34 | $2,274 | $53 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $1,979 | $53 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,708 | $107 |
| Removal of fingernails or toenails, 6 or more nails | 62 | $1,605 | $19 |
| Return visit (30+ min) | 17 | $1,125 | $62 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $438 | $19 |
| Removal of noncancer thickened skin growth, 1 growth | 15 | $270 | $14 |
2021: 8 services
| Short return visit (20+ min) | 57 | $4,118 | $56 |
| Removal of skin and tissue, 20.0 sq cm or less | 30 | $3,127 | $54 |
| Return visit (30+ min) | 14 | $1,311 | $94 |
| Removal of fingernails or toenails, 6 or more nails | 42 | $975 | $19 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $959 | $53 |
| Short return visit | 13 | $398 | $28 |
| Removal of noncancer thickened skin growth, 1 growth | 14 | $242 | $13 |
| Removal of noncancer thickened skin growth, 2-4 growths | 14 | $220 | $15 |
2020: 6 services
| Return visit (30+ min) | 29 | $4,100 | $67 |
| Short return visit (20+ min) | 63 | $3,576 | $41 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $1,701 | $57 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $705 | $39 |
| Removal of fingernails or toenails, 6 or more nails | 26 | $613 | $21 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $399 | $22 |
2019: 2 services
| Short return visit (20+ min) | 55 | $3,205 | $43 |
| Removal of fingernails or toenails, 6 or more nails | 21 | $461 | $21 |
Medicaid work
$28,560 in 2024
Medicaid paid $28,560 for 3,828 billed services this clinician did in 2024, up to 89 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 359 | $7,800 |
| Short return visit (20+ min) | 471 | $5,412 |
| Service | 102 | $3,923 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 219 | $2,936 |
| Debridement of nail(s) by any method(s); 6 or more | 610 | $1,845 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 119 | $1,224 |
| Service | 26 | $1,082 |
| Short return visit | 40 | $1,021 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 200 | $956 |
| Return visit (30+ min) | 84 | $497 |
| Hospital outpatient clinic visit for assessment and management of a patient | 13 | $425 |
| REMOVAL OF NAIL PLATE | 16 | $387 |
| 2024 | 3,828 | 22 | 89 | $28,560 |
| 2023 | 1,744 | 10 | 59 | $7,793 |
| 2022 | 996 | 7 | 63 | $4,539 |
| 2021 | 678 | 5 | 48 | $3,437 |
| 2020 | 494 | 5 | 46 | $2,140 |
| 2019 | 67 | 1 | 50 | $400 |
See the largest Medicaid services in earlier years
2023
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 240 | $3,076 |
| Short return visit (20+ min) | 428 | $1,832 |
| Debridement of nail(s) by any method(s); 6 or more | 394 | $1,226 |
| New patient visit (30+ min) | 97 | $741 |
| Service | 409 | $374 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 54 | $219 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 60 | $160 |
| Short return visit | 28 | $88 |
| Return visit (30+ min) | 13 | $76 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 21 | $0 |
2022
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 118 | $2,008 |
| Short return visit (20+ min) | 438 | $1,465 |
| Debridement of nail(s) by any method(s); 6 or more | 319 | $759 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 51 | $149 |
| Short return visit | 13 | $58 |
| Return visit (30+ min) | 32 | $51 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 25 | $50 |
2021
| Short return visit (20+ min) | 419 | $2,171 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 80 | $708 |
| Debridement of nail(s) by any method(s); 6 or more | 128 | $421 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 27 | $71 |
| Short return visit | 24 | $66 |
2020
| Short return visit (20+ min) | 301 | $1,292 |
| Return visit (30+ min) | 79 | $380 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 37 | $219 |
| Debridement of nail(s) by any method(s); 6 or more | 65 | $190 |
| Short return visit | 12 | $59 |
2019
| Short return visit (20+ min) | 67 | $400 |
Drugs they prescribed that Part D paid
$2,755
Pharmacies billed $2,755 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
141 generic and 0 brand-name prescriptions · $2,755 in drug cost · 28 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ammonium Lactate | 44 | $879 | $20 |
| Clotrimazole | 22 | $727 | $33 |
| Diclofenac | 19 | $394 | $21 |
| Amoxicillin-Clavulanate Potass | 14 | $152 | $11 |
Year by year
| 2024 | 141 | 60 | None | 0% | $2,755 |
| 2023 | 94 | 54 | None | None | $2,848 |
| 2022 | 59 | 26 | None | None | $2,915 |
| 2021 | 80 | 40 | None | 14% | $7,887 |
| 2020 | 49 | 21 | 0% (0) | None | $1,063 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Ammonium Lactate | 35 | $887 | $25 |
| Clotrimazole | 18 | $685 | $38 |
2022: 2 drugs
| Ammonium Lactate | 17 | $499 | $29 |
| Clotrimazole | 11 | $431 | $39 |
2021: 4 drugs
| Santyl | 11 | $5,775 | $525 |
| Clotrimazole | 16 | $697 | $44 |
| Ammonium Lactate | 18 | $501 | $28 |
| Diclofenac | 11 | $240 | $22 |
2020: 1 drug
| Clotrimazole | 12 | $231 | $19 |
Money from drug and device companies
$14 in 2024
| 2024 | 1 | 1 | None | $14 |
| 2022 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Collagenase Santyl | $14 | 1 payment
|
See the published payment
| Smith+Nephew | Meals · 2024-10-04 | Collagenase Santyl | $14 |
See earlier years (2022)
2022: $23
| Smith+Nephew | Grafix Pl | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1669836763
- Licence
- CA E5567
- Trained
- California School of Podiatric Medicine, 2016
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 975 Sereno Dr, Vallejo, CA, 94589
- NPI first listed
- 2016-04-05
- NPI last updated
- 2019-07-22
This is when the NPI record was last certified, not a medical board exam.